UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
----------------------
FORM 8-K/A
AMENDMENT NO. 1 TO CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 28, 2005
CRDENTIA CORP.
(Exact name of registrant as specified in its charter)
Delaware 000-31152 76-0585701
(State or Other Jurisdiction of (Commission (I.R.S. Employer
Incorporation) File Number) Identification Number)
14114 Dallas Parkway, Suite 600
Dallas, Texas 75254
(Address of Principal Executive Offices) (Zip Code)
(972) 850-0780
(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
|_| Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 2.01 Completion of Acquisition or Disposition of Assets.
On March 29, 2005, we, Crdentia Corp., CRDE Corp., a wholly-owned
subsidiary of Crdentia Corp., TravMed Acquisition Corporation, a wholly-owned
subsidiary of CRDE Corp., TravMed USA, Inc. ("TravMed"), and the shareholders of
TravMed completed the merger of TravMed Acquisition Corporation with and into
TravMed USA, Inc. pursuant to the terms of the Agreement and Plan of
Reorganization dated March 28, 2005.
We hereby amend Item 9.01 of our current report on Form 8-K filed on April
1, 2005 to include financial statements of the business acquired and pro forma
financial information in accordance with Items 9.01(a) and (b) within 71
calendar days after the date on which the initial report on Form 8-K was
required to be filed. Except as set forth in Item 9.01 below, no other changes
are being made to our current report on Form 8-K filed on April 1, 2005.
Item 9.01 Financial Statements and Exhibits.
(a) Financial Statements of Businesses Acquired.
The financial statements of TravMed USA, Inc. and selected accounts of its
affiliate required to be filed pursuant to Item 9.01(a) of Form 8-K are attached
hereto as Exhibit 99.1.
(b) Pro Forma Financial Information.
The pro forma financial information required to be filed pursuant to Item
9.01(b) of Form 8-K is attached hereto as Exhibit 99.2.
(c) Exhibits.
Exhibit No. Description
----------- --------------------------------------------------------
99.1 Financial Statements of TravMed USA, Inc. and selected
accounts of its affiliate
99.2 Pro Forma Financial Information
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CRDENTIA CORP.
June 13, 2005 By: /s/ James J. TerBeest
------------------------------------
James J. TerBeest
Chief Financial Officer
EXHIBIT INDEX
Exhibit No. Description
----------- --------------------------------------------------------------
99.1 Financial Statements of TravMed USA, Inc. and selected
accounts of its affiliate
99.2 Pro Forma Financial Information